- Joined
- Sep 23, 2005
- Messages
- 1,061
- Reaction score
- 6
the subject of reimbursements came up today in the context of thyroid disease . . . according to a well-respected endocrinologist, the Medicare/Medicaid reimbursements will soon be falling for thyroid biopsies, due to the low-impact nature of the procedure (i.e. majority are for benign nodules). his argument may have been more convincing than what i've just outlined, but then again he understands it better than me.
but, my question is: could we possibly see the same change selected for derm specimens (shaves and punches)? i mean, most are a lot less involved than obtaining a gastric bx or a colon bx, but currently most are billed as 88305's just the same. Will Medicare catch on?
consider the endarterectomy: what was once a procedure that could bill up to $10,000, is now something in the $1,500 range due to the fact that, well, people just got better at them . . . (give me a break on the exact numbers, its the principle of a specific procedure/specimen being singled out for reduced reimbursement that is the point i am trying to get at) . . .
thoughts . . . ?
but, my question is: could we possibly see the same change selected for derm specimens (shaves and punches)? i mean, most are a lot less involved than obtaining a gastric bx or a colon bx, but currently most are billed as 88305's just the same. Will Medicare catch on?
consider the endarterectomy: what was once a procedure that could bill up to $10,000, is now something in the $1,500 range due to the fact that, well, people just got better at them . . . (give me a break on the exact numbers, its the principle of a specific procedure/specimen being singled out for reduced reimbursement that is the point i am trying to get at) . . .
thoughts . . . ?